AKYILDIZ, A. Et Al. 2024. Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer. JAPANESE JOURNAL OF CLINICAL ONCOLOGY .

AKYILDIZ, A., Ismayilov, R., Abdurrahimli, N., Ormanci, A., GÜVEN, D. C., TUNCEL, M., ... ONUR, M. R.(2024). Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer. JAPANESE JOURNAL OF CLINICAL ONCOLOGY .

AKYILDIZ, ARİF Et Al. "Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer," JAPANESE JOURNAL OF CLINICAL ONCOLOGY , 2024

AKYILDIZ, ARİF Et Al. "Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer." JAPANESE JOURNAL OF CLINICAL ONCOLOGY , 2024

AKYILDIZ, A. Et Al. (2024) . "Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer." JAPANESE JOURNAL OF CLINICAL ONCOLOGY .

@article{article, author={ARİF AKYILDIZ Et Al. }, title={Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer}, journal={JAPANESE JOURNAL OF CLINICAL ONCOLOGY}, year=2024}